Eli Lilly, Walmart
Digest more
U.S. sales of Lilly’s weight-loss treatment Zepbound nearly tripled to $3.57 billion in the third quarter. Meanwhile, revenue ...
Outside of the core registrational programs for these two important indications, we have several additional ongoing phase ...
Revenue from Mounjaro, the company’s Type 2 diabetes treatment, came in at $6.5 billion, above analysts’ consensus estimate ...
In parallel with mazisotine’s shelving, Lilly added a phase 1 NaV1.8 inhibitor from its SiteOne Therapeutics acquisition to ...
Eli Lilly (LLY) is one of Nvidia's (NVDA) many partners announced by the artificial intelligence (AI) chipmaker. The two ...
Eli Lilly reported strong earnings and raised guidance. Read more on what could be next for this biotech giant.
(Reuters) -Eli Lilly said on Wednesday it will invest more than $1.2 billion to expand its manufacturing site in Puerto Rico, ...
Eli Lilly shares surged after strong third-quarter results and a raised annual forecast, powered by booming demand for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback